J Dermatol Case Rep (2014) 8(3):606
If you're not in a caloric deficit and you don't have B12 deficiency, you're paying $40$60 per week for negligible benefit
CuNPs toxic properties appear to result from oxidative stress and protein damage, DNA damage and membrane damage
The evolution of this technology from concept to clinical application can be delineated into three major phases (Fig
Marc Dunoyer, the companys rare disease head, in a statement called Ultomiris a transformative treatment option for NMOSD, with the potential to eliminate relapses with a convenient dosing schedule every eight weeks. The approval was backed by data from a Phase III trial that met its primary efficacy endpoint, preventing relapse in all 58 treated patients over a median of 73.5 weeks, compared to 20 relapses in the placebo arm of a trial for AstraZenecas other NMOSD therapy Soliris
Vitamin B12 is mainly found in animal products like meat, fish, and eggs